Clinical and pathologic features of families with LRRK2-associated Parkinson's disease
- PMID: 17017533
- DOI: 10.1007/978-3-211-45295-0_34
Clinical and pathologic features of families with LRRK2-associated Parkinson's disease
Abstract
The etiology for Parkinson's disease (PD) remains unknown. Genetic causes have been identified with several distinct mutations. Recently, 9 mutations involving a novel gene, leucine-rich repeat kinase 2 (LRRK2), have been identified as the cause of autosomal dominant PD in kindreds, with some of them previously linked to the PARK8 locus on chromosome 12. LRRK2 mutations are relatively common genetic causes of familial and sporadic PD. In addition, these mutations have been identified in diverse populations. The clinical and pathologic features of LRRK2-associated PD are indistinguishable from idiopathic PD; however, considerable clinical and pathologic variability exists even among kindreds. This short review highlights the clinical and pathologic features in LRRK2-associated parkinsonism.
Similar articles
-
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.Brain. 2005 Dec;128(Pt 12):2786-96. doi: 10.1093/brain/awh667. Epub 2005 Nov 4. Brain. 2005. PMID: 16272164
-
PARK8 LRRK2 parkinsonism.Curr Neurol Neurosci Rep. 2006 Jul;6(4):287-94. doi: 10.1007/s11910-006-0020-0. Curr Neurol Neurosci Rep. 2006. PMID: 16822348 Review.
-
[Clinical molecular genetics for PARK8 (LRRK2)].Brain Nerve. 2007 Aug;59(8):839-50. Brain Nerve. 2007. PMID: 17713120 Review. Japanese.
-
A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.Eur J Neurol. 2007 Apr;14(4):413-7. doi: 10.1111/j.1468-1331.2007.01685.x. Eur J Neurol. 2007. PMID: 17388990
-
LRRK2 in Parkinson's disease: protein domains and functional insights.Trends Neurosci. 2006 May;29(5):286-93. doi: 10.1016/j.tins.2006.03.006. Epub 2006 Apr 17. Trends Neurosci. 2006. PMID: 16616379 Review.
Cited by
-
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1.Nat Commun. 2016 Jun 7;7:11792. doi: 10.1038/ncomms11792. Nat Commun. 2016. PMID: 27273569 Free PMC article.
-
Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export.EMBO J. 2014 Oct 16;33(20):2314-31. doi: 10.15252/embj.201487807. Epub 2014 Sep 8. EMBO J. 2014. PMID: 25201882 Free PMC article.
-
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.Neurobiol Dis. 2010 Dec;40(3):503-17. doi: 10.1016/j.nbd.2010.07.010. Epub 2010 Jul 24. Neurobiol Dis. 2010. PMID: 20659558 Free PMC article.
-
Evolution of neurodegeneration.Curr Biol. 2012 Sep 11;22(17):R753-61. doi: 10.1016/j.cub.2012.07.008. Curr Biol. 2012. PMID: 22975006 Free PMC article. Review.
-
Medical management of Parkinson's disease.P T. 2008 Oct;33(10):590-606. P T. 2008. PMID: 19750042 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical